Recruiting B-Cell Acute Lymphoblastic Leukemia Studies in Birmingham
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial al...
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come ...
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
This pilot trial assesses the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemotherapy for treating patients with Philadelphia chromosome positive (Ph+) or ABL-cl...
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
This study will evaluate the use of non- TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal resi...
About B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Birmingham
B-cell acute lymphoblastic leukemia (B-ALL) is a fast-growing cancer of the B-type lymphocyte white blood cells. It is the most common childhood cancer but can also occur in adults. Treatment includes chemotherapy, targeted therapy, and CAR-T cell therapy.
There are currently 4 b-cell acute lymphoblastic leukemia clinical trials recruiting participants in Birmingham, ALABAMA. These studies are seeking a combined 5,775 participants. Research is being sponsored by Children's Oncology Group, National Cancer Institute (NCI), Pediatric Transplantation & Cellular Therapy Consortium. Clinical trial participation is free and participants receive study-related medical care at no cost.
B-Cell Acute Lymphoblastic Leukemia Clinical Trials in Birmingham — FAQ
Are there b-cell acute lymphoblastic leukemia clinical trials in Birmingham?
Yes, there are 4 b-cell acute lymphoblastic leukemia clinical trials currently recruiting in Birmingham, ALABAMA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Birmingham?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.
Are clinical trials in Birmingham free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.
What b-cell acute lymphoblastic leukemia treatments are being tested?
The 4 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for b-cell acute lymphoblastic leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov